David Fajgenbaum
David Fajgenbaum is an American immunologist and researcher known for his work in the field of Castleman disease. He is an assistant professor at the University of Pennsylvania and the co-founder of the Castleman Disease Collaborative Network (CDCN).
Early Life and Education[edit | edit source]
David Fajgenbaum was born in Raleigh, North Carolina. He attended Georgetown University, where he played football and graduated with a degree in Human Sciences. He later earned a Master of Science in Public Health from the University of Oxford and a Doctor of Medicine (MD) from the Perelman School of Medicine at the University of Pennsylvania.
Career[edit | edit source]
Fajgenbaum's career took a significant turn when he was diagnosed with idiopathic multicentric Castleman disease (iMCD) during medical school. This rare and life-threatening condition led him to focus his research on finding a cure. He co-founded the Castleman Disease Collaborative Network (CDCN) to accelerate research and treatment for the disease.
Research and Contributions[edit | edit source]
David Fajgenbaum's research has been pivotal in understanding and treating Castleman disease. He has published numerous papers on the subject and has been involved in the development of new treatment protocols. His work has been recognized with several awards and honors in the medical community.
Personal Life[edit | edit source]
Fajgenbaum is married and has children. He has written a memoir titled Chasing My Cure: A Doctor's Race to Turn Hope Into Action, which details his personal and professional journey with Castleman disease.
Publications[edit | edit source]
- Chasing My Cure: A Doctor's Race to Turn Hope Into Action
See Also[edit | edit source]
- Castleman disease
- University of Pennsylvania
- Perelman School of Medicine at the University of Pennsylvania
- Georgetown University
- University of Oxford
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD